indomethacin has been researched along with Cyanosis in 3 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two twins born to a mother who had been treated with Indomethacin at the end of pregnancy presented with variable but transitory hypoxemia." | 7.66 | [Twin pregnancy, indomethacin and neonatal cyanosis (author's transl)]. ( Boulley, AM; Dehan, M; Gabilan, JC; Hernandorena, X; Laudignon, N; Lhermitte, C; Ropert, JC; Vial, M, 1980) |
| "Two twins born to a mother who had been treated with Indomethacin at the end of pregnancy presented with variable but transitory hypoxemia." | 3.66 | [Twin pregnancy, indomethacin and neonatal cyanosis (author's transl)]. ( Boulley, AM; Dehan, M; Gabilan, JC; Hernandorena, X; Laudignon, N; Lhermitte, C; Ropert, JC; Vial, M, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Distefano, G | 1 |
| Boulley, AM | 1 |
| Dehan, M | 1 |
| Vial, M | 1 |
| Hernandorena, X | 1 |
| Ropert, JC | 1 |
| Laudignon, N | 1 |
| Lhermitte, C | 1 |
| Gabilan, JC | 1 |
| Sharpe, GL | 1 |
| Thalme, B | 1 |
| Larsson, KS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Liberal Versus Restrictive Platelet Transfusion for Treatment of Hemodynamically Significant Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates- A Randomized Open Label, Controlled Trial[NCT03022253] | Phase 3 | 44 participants (Anticipated) | Interventional | 2016-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for indomethacin and Cyanosis
| Article | Year |
|---|---|
[The pharmacological manipulation of Botallo's duct in the duct-dependent congenital cardiopathies and in the preterm infants with respiratory distress. A review and personal findings].
Topics: Alprostadil; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Agents; Cerebral Angiography; C | 2005 |
2 other studies available for indomethacin and Cyanosis
| Article | Year |
|---|---|
[Twin pregnancy, indomethacin and neonatal cyanosis (author's transl)].
Topics: Adult; Cyanosis; Diseases in Twins; Female; Humans; Indomethacin; Infant, Newborn; Infant, Newborn, | 1980 |
Studies on closure of the ductus arteriosus. XI. Ductal closure in utero by a prostaglandin synthetase inhibitor.
Topics: Animals; Blood; Carbon Dioxide; Cyanosis; Ductus Arteriosus; Female; Fetus; Hydrogen-Ion Concentrati | 1974 |